Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-066178

Neurogene Inc. · NGNE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Lloyd MacKenzie
Officer — VP Technical Operations
Period of report
Aug 12, 2015
Accepted (ET)
Aug 14, 2015 · 8:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001404644

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 12, 2015M7,812$5.76A7,812D
Common StockAug 12, 2015M28,075$5.76A35,887D
Common StockF1Aug 12, 2015S35,887$18.67D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2$5.76Aug 12, 2015M7,812A—Jun 10, 2020Common Stock7,8120D
Stock Option (Right to Buy)F3$5.76Aug 12, 2015M28,075A—Nov 10, 2021Common Stock28,0751,872D

Explanation of responses